drugset
drugset / Trial / NCT00331981

Amisulpride in Schizophrenic Patients

NCT00331981 ↗

Phase 4 Completed 138 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Primary purpose: * To find out how effective is long term treatment with amisulpride on the positive and negative symptoms in schizophrenic patients * To find out how safe is long term treatment with amisulpride in schizophrenic patients Secondary purpose: * To find out how effective is long term treatment with amisulpride on the quality of life in schizophrenic patients * To find out how effective is long term treatment with amisulpride on the cognitive function in schizophrenic patients

Timeline

Start
2004-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Amisulpride Small molecule — —

Indications

schizophrenia